THE CLINICAL EVALUATION OF AUREOMYCIN

^{Infectious Disease Laboratory 4 of the San Francisco Hospital, Berkeley, California}

^{State of California Virus and Rickettsial Disease Laboratory, Berkeley, California}

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

Aided by grants from C. S. Howard Donation and the Fleischner Endowment Fund.

The aureomycin used in this investigation was provided by Lederle Laboratories, Division of the American Cyanamid Company.

This laboratory is supported by the Divisions of Medicine and Pediatrics of the University of California Medical School and by the Department of Public Health of the City and County of San Francisco, California.

Find articles by Brainerd, H. in: PubMed | Google Scholar

^{Infectious Disease Laboratory 4 of the San Francisco Hospital, Berkeley, California}

^{State of California Virus and Rickettsial Disease Laboratory, Berkeley, California}

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

Aided by grants from C. S. Howard Donation and the Fleischner Endowment Fund.

The aureomycin used in this investigation was provided by Lederle Laboratories, Division of the American Cyanamid Company.

This laboratory is supported by the Divisions of Medicine and Pediatrics of the University of California Medical School and by the Department of Public Health of the City and County of San Francisco, California.

Find articles by Lennette, E. in: PubMed | Google Scholar

^{Infectious Disease Laboratory 4 of the San Francisco Hospital, Berkeley, California}

^{State of California Virus and Rickettsial Disease Laboratory, Berkeley, California}

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

Aided by grants from C. S. Howard Donation and the Fleischner Endowment Fund.

The aureomycin used in this investigation was provided by Lederle Laboratories, Division of the American Cyanamid Company.

This laboratory is supported by the Divisions of Medicine and Pediatrics of the University of California Medical School and by the Department of Public Health of the City and County of San Francisco, California.

Find articles by Meiklejohn, G. in: PubMed | Google Scholar

^{Infectious Disease Laboratory 4 of the San Francisco Hospital, Berkeley, California}

^{State of California Virus and Rickettsial Disease Laboratory, Berkeley, California}

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

Aided by grants from C. S. Howard Donation and the Fleischner Endowment Fund.

The aureomycin used in this investigation was provided by Lederle Laboratories, Division of the American Cyanamid Company.

This laboratory is supported by the Divisions of Medicine and Pediatrics of the University of California Medical School and by the Department of Public Health of the City and County of San Francisco, California.

Find articles by Bruyn, H. in: PubMed | Google Scholar

^{Infectious Disease Laboratory 4 of the San Francisco Hospital, Berkeley, California}

^{State of California Virus and Rickettsial Disease Laboratory, Berkeley, California}

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

Aided by grants from C. S. Howard Donation and the Fleischner Endowment Fund.

The aureomycin used in this investigation was provided by Lederle Laboratories, Division of the American Cyanamid Company.

This laboratory is supported by the Divisions of Medicine and Pediatrics of the University of California Medical School and by the Department of Public Health of the City and County of San Francisco, California.

Find articles by Clark, W. in: PubMed | Google Scholar